Probiotic
Live microorganisms that, when administered in adequate amounts, confer a health benefit on the host. In dogs, strain-specific probiotics support gut health, immune function, and may influence systemic inflammation.
Probiotics are live microorganisms — primarily bacteria and some yeasts — that provide health benefits when consumed in sufficient quantities. The WHO definition requires that a strain must be alive, administered in adequate dose, and have demonstrated benefit to qualify as a probiotic. Not all bacteria marketed as probiotics meet this standard.
Strain Specificity
The most critical concept in probiotic science is strain specificity: benefits demonstrated for one bacterial strain do not automatically apply to another, even within the same species. Lactobacillus acidophilus strain A may have clinical evidence while strain B does not. Product labels should list specific strains (not just genus and species) and colony-forming units (CFUs).
Strains with veterinary evidence in dogs include:
- Enterococcus faecium SF68: reduced duration of acute diarrhea in dogs (multiple RCTs)
- Bacillus subtilis, Bacillus licheniformis: spore-forming probiotics with improved shelf stability
- Saccharomyces boulardii: a yeast probiotic effective in acute enteritis
Gut Health Mechanisms
Probiotics support gut health through several mechanisms:
- Competitive exclusion: beneficial bacteria occupy mucosal binding sites, preventing pathogen colonization
- Barrier function: enhance tight junction integrity between intestinal epithelial cells, reducing “leaky gut”
- Short-chain fatty acid (SCFA) production: fermentation of fiber by probiotic bacteria produces butyrate, propionate, and acetate — fuels for colonocytes and anti-inflammatory signaling molecules
- Immune modulation: interact with gut-associated lymphoid tissue (GALT) to modulate immune responses — relevant for inflammatory bowel disease and food allergy management
Evidence in Dogs
The evidence base for probiotics in dogs is growing but uneven:
- Acute diarrhea: moderate evidence for reduced severity and duration
- Antibiotic-associated dysbiosis: some evidence for maintaining microbiome diversity during antibiotic therapy
- Atopic dermatitis: preliminary evidence for immune modulation; not a standalone treatment
- Longevity: the gut microbiome is linked to aging and longevity, but direct evidence that probiotic supplementation extends lifespan in dogs is not yet established
Pairing with Prebiotics
Prebiotics are non-digestible fibers that feed beneficial gut bacteria. Combining probiotics with prebiotics (a “synbiotic”) may enhance probiotic colonization and SCFA production. Common prebiotic fibers include inulin, fructooligosaccharides (FOS), and beet pulp.
Product Quality
Probiotic product quality varies enormously. Key considerations:
- CFU count: products should guarantee CFU count at time of expiration, not time of manufacture
- Strain identification: products listing only genus/species without strain codes lack accountability
- Viability: many commercial products contain dead or insufficient bacteria at time of use
- NASC quality seal: the National Animal Supplement Council seal indicates adherence to quality manufacturing standards
Dosing
Typical dosing range: 1-10 billion CFU/day for dogs, depending on body weight and product concentration. Higher doses may be appropriate during active GI disease or antibiotic therapy. Probiotics are extremely safe — adverse effects are essentially unreported in dogs.